title: Fondaparinux in atrial fibrillation – old dog, new tricks?
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, B18 7QH, Birmingham, United Kingdom.
authors.forename: Yee C
authors.initials: YC
authors.lastname: Lau
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, B18 7QH, Birmingham, United Kingdom.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Brown
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, B18 7QH, Birmingham, United Kingdom. Electronic address: g.y.h.lip@bham.ac.uk.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D004554:Electric Countershock; D005170:Factor X / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000627:therapeutic use*; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D005170:Factor X
keywords: Anticoagulation; Atrial fibrillation; Fibrillation atriale; Fondaparinux; Traitement anticoagulant